Antiviral Research

Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90.  185. 2021

Mark Prichard: Scholar, family man and friend.  176. 2020

NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.  170. 2019

New therapies for human cytomegalovirus infections.  159:153-174. 2018

Comparison of antiviral resistance across acute and chronic viral infections.  158:103-112. 2018

Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures.  150:164-173. 2018

Benzimidazole analogs inhibit respiratory syncytial virus G protein function.  121:31-38. 2015

Antiviral therapy for herpesvirus central nervous system infections: Neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.  83:207-213. 2009

Herpes simplex encephalitis: Adolescents and adults.  71:141-148. 2006

Recent development of therapeutics for chronic HCV infection.  71:351-362. 2006

Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.  63:141-151. 2004

HSV shedding.  63. 2004

HSV-2 transmission.  63. 2004

Lessons from HIV and hepatitis viruses.  63. 2004

Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?.  63. 2004

Smallpox: A potential agent of bioterrorism.  57:7-12. 2003

Juvenile onset recurrent respiratory papillomatosis: Possibilities for successful antiviral therapy.  45:83-93. 2000

Herpes zoster: Focus on treatment in older adults.  44:145-154. 1999

Effect of recombinant human interferon α B/D (rHu-IFN-α B/D) in combination with acyclovir in experimental HSV-1 encephalitis.  44:75-78. 1999

Comparison of antiviral compounds against human herpesvirus 6 and 7.  40:73-84. 1998

Summary of the III international consensus symposium on combined antiviral therapy.  38:75-93. 1998

A randomized, double-blind trial of parenteral low dose versus high dose interferon-β in combination with cryotherapy for treatment of condyloma acuminatum.  35:41-52. 1997

Assessment of pain in herpes zoster: Lessons learned from antiviral trials.  33:73-85. 1997

Summary of the International Consensus Symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection.  32:119-140. 1996

Differential effect of recombinant human and mouse interferons on replication of herpes simplex virus type 1 in mouse cells.  32:27-34. 1996

Unique clinical trial design: Combination acyclovir plus prednisone therapy of localized zoster in the normal host.  29:67-68. 1996

Antiviral resistance - an emerging problem.  26:365-368. 1995

Antiviral resistance in clinical practice.  26:423-438. 1995

Assays for antiviral drug resistance.  26:403-413. 1995

Models of antiviral resistance.  26:415-422. 1995

Molecular mechanisms of antiviral resistance.  26:369-401. 1995

Research initiatives in studies of antiviral resistance and consensus points and recommendations.  26:439-452. 1995

Antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1.  20:293-303. 1993

SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.  21:15-35. 1993

Interference with HIV-1 reverse transcriptase-catalyzed DNA chain elongation by the 5′-triphosphate of the carbocyclic analog of 2′-deoxyguanosine.  19:325-332. 1992

Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1.  19:181-192. 1992

Editorial.  11:1-2. 1989